Veterinary Translational Project Consulting & Scientific Program Leadership
From disease biology to development execution – veterinary-scientific leadership for translational programs.
Bringing a new therapy into clinical development requires more than project management. It requires deep biological understanding of disease mechanisms, robust translational hypotheses, appropriate model systems, and scientifically sound decision-making across preclinical and early clinical phases.
I support biotech companies and academic spin-offs as an independent veterinary scientist and translational consultant, providing interim scientific leadership and hands-on program guidance for biologically complex development projects.
Whether you are advancing a late preclinical program or entering early clinical development, I contribute veterinary-medical expertise to ensure scientific rigor, biological relevance, and translational coherence across disciplines.
What’s included:
- Interim scientific leadership of translational development programs
- Veterinary-medical assessment of disease biology, mechanisms of action, and model relevance
- Integration of preclinical data, biomarkers, and translational hypotheses into development strategy
- Structuring of decision processes based on biological risk and scientific evidence
- Scientific coordination of interdisciplinary project teams and external partners
- Support of program governance, milestone definition, and evidence-based prioritization
This is ideal if you:
- Need experienced scientific leadership for a complex translational program
- Want to strengthen biological robustness and medical relevance of your development strategy
- Are preparing the transition from preclinical research into early clinical development
Translational Strategy, Biomarker Development & IND/CTA Readiness Consulting
Design translational programs that generate medically meaningful evidence – not just regulatory documents.
IND/CTA readiness is not primarily a regulatory exercise. It is a scientific process of demonstrating biological relevance, mechanistic understanding, and translational validity of your therapeutic concept.
As a veterinarian with long-standing experience in translational science and clinical biomarker leadership, I support the design of biomarker strategies and translational development concepts that link disease biology, pharmacology, and clinical decision-making.
My consulting focuses on the medical-scientific substance behind regulatory readiness – ensuring that your program generates the right data to support future clinical decisions.
What’s included:
- Development of biologically grounded translational and biomarker strategies
- Veterinary-medical evaluation of pharmacodynamic markers, target engagement, and disease relevance
- Selection and scientific governance of external laboratories, assays, and diagnostic partners
- Sample strategy, data interpretation frameworks, and translational decision criteria
- Scientific gap and risk analysis for IND/CTA readiness
- Advisory input on scientific sections of IBs, IMPDs, and clinical protocols
This is ideal if you:
- Are approaching IND/CTA and want biologically robust translational readiness
- Have strong preclinical data but limited translational strategy
- Need scientifically grounded biomarker concepts rather than generic templates